ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

November 27, 2009

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014